1 2616 199 YOGA FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE. BACKGROUND: CORONARY HEART DISEASE (CHD) IS THE MAJOR CAUSE OF EARLY MORBIDITY AND MORTALITY IN MOST DEVELOPED COUNTRIES. SECONDARY PREVENTION AIMS TO PREVENT REPEAT CARDIAC EVENTS AND DEATH IN PEOPLE WITH ESTABLISHED CHD. LIFESTYLE MODIFICATIONS PLAY AN IMPORTANT ROLE IN SECONDARY PREVENTION. YOGA HAS BEEN REGARDED AS A TYPE OF PHYSICAL ACTIVITY AS WELL AS A STRESS MANAGEMENT STRATEGY. GROWING EVIDENCE SUGGESTS THE BENEFICIAL EFFECTS OF YOGA ON VARIOUS AILMENTS. OBJECTIVES: TO DETERMINE THE EFFECTIVENESS OF YOGA FOR THE SECONDARY PREVENTION OF MORTALITY AND MORBIDITY IN, AND ON THE HEALTH-RELATED QUALITY OF LIFE OF, INDIVIDUALS WITH CHD. SEARCH METHODS: THIS IS AN UPDATE OF A REVIEW PREVIOUSLY PUBLISHED IN 2012. FOR THIS UPDATED REVIEW, WE SEARCHED THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL) IN THE COCHRANE LIBRARY (ISSUE 1 OF 12, 2014), MEDLINE (1948 TO FEBRUARY WEEK 1 2014), EMBASE (1980 TO 2014 WEEK 6), WEB OF SCIENCE (THOMSON REUTERS, 1970 TO 12 FEBRUARY 2014), CHINA JOURNAL NET (1994 TO MAY 2014), WANFANG DATA (1990 TO MAY 2014), AND INDEX TO CHINESE PERIODICALS OF HONG KONG (HKINCHIP) (FROM 1980). ONGOING STUDIES WERE IDENTIFIED IN THE METAREGISTER OF CONTROLLED TRIALS (MAY 2014) AND THE WORLD HEALTH ORGANIZATION INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM (MAY 2014). WE APPLIED NO LANGUAGE RESTRICTIONS. SELECTION CRITERIA: WE PLANNED TO INCLUDE RANDOMISED CONTROLLED TRIALS (RCTS) INVESTIGATING THE INFLUENCE OF YOGA PRACTICE ON CHD OUTCOMES IN MEN AND WOMEN (AGED 18 YEARS AND OVER) WITH A DIAGNOSIS OF ACUTE OR CHRONIC CHD. STUDIES WERE ELIGIBLE FOR INCLUSION IF THEY HAD A FOLLOW-UP DURATION OF SIX MONTHS OR MORE. WE CONSIDERED STUDIES THAT COMPARED ONE GROUP PRACTICING A TYPE OF YOGA WITH A CONTROL GROUP RECEIVING EITHER NO INTERVENTION OR INTERVENTIONS OTHER THAN YOGA. DATA COLLECTION AND ANALYSIS: TWO AUTHORS INDEPENDENTLY SELECTED STUDIES ACCORDING TO PRESPECIFIED INCLUSION CRITERIA. WE RESOLVED DISAGREEMENTS EITHER BY CONSENSUS OR BY DISCUSSION WITH A THIRD AUTHOR. MAIN RESULTS: WE FOUND NO ELIGIBLE RCTS THAT MET THE INCLUSION CRITERIA OF THE REVIEW AND THUS WE WERE UNABLE TO PERFORM A META-ANALYSIS. AUTHORS' CONCLUSIONS: THE EFFECTIVENESS OF YOGA FOR SECONDARY PREVENTION IN CHD REMAINS UNCERTAIN. LARGE RCTS OF HIGH QUALITY ARE NEEDED. 2015 2 2629 92 YOGA FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE. BACKGROUND: A SEDENTARY LIFESTYLE AND STRESS ARE MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD). SINCE YOGA INVOLVES EXERCISE AND IS THOUGHT TO HELP IN STRESS REDUCTION IT MAY BE AN EFFECTIVE STRATEGY IN THE PRIMARY PREVENTION OF CVD. OBJECTIVES: TO DETERMINE THE EFFECT OF ANY TYPE OF YOGA ON THE PRIMARY PREVENTION OF CVD. SEARCH METHODS: WE SEARCHED THE FOLLOWING ELECTRONIC DATABASES: THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL) (2013, ISSUE 11) IN THE COCHRANE LIBRARY; MEDLINE (OVID) (1946 TO NOVEMBER WEEK 3 2013); EMBASE CLASSIC + EMBASE (OVID) (1947 TO 2013 WEEK 48); WEB OF SCIENCE (THOMSON REUTERS) (1970 TO 4 DECEMBER 2013); DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE), HEALTH TECHNOLOGY ASSESSMENT DATABASE AND HEALTH ECONOMICS EVALUATIONS DATABASE (ISSUE 4 OF 4, 2013) IN THE COCHRANE LIBRARY. WE ALSO SEARCHED A NUMBER OF ASIAN DATABASES AND THE ALLIED AND COMPLEMENTARY MEDICINE DATABASE (AMED) (INCEPTION TO DECEMBER 2012). WE SEARCHED TRIAL REGISTERS AND REFERENCE LISTS OF REVIEWS AND ARTICLES, AND APPROACHED EXPERTS IN THE FIELD. WE APPLIED NO LANGUAGE RESTRICTIONS. SELECTION CRITERIA: RANDOMISED CONTROLLED TRIALS LASTING AT LEAST THREE MONTHS INVOLVING HEALTHY ADULTS OR THOSE AT HIGH RISK OF CVD. TRIALS EXAMINED ANY TYPE OF YOGA AND THE COMPARISON GROUP WAS NO INTERVENTION OR MINIMAL INTERVENTION. OUTCOMES OF INTEREST WERE CLINICAL CVD EVENTS AND MAJOR CVD RISK FACTORS. WE DID NOT INCLUDE ANY TRIALS THAT INVOLVED MULTIFACTORIAL LIFESTYLE INTERVENTIONS OR WEIGHT LOSS. DATA COLLECTION AND ANALYSIS: TWO AUTHORS INDEPENDENTLY SELECTED TRIALS FOR INCLUSION, EXTRACTED DATA AND ASSESSED THE RISK OF BIAS. MAIN RESULTS: WE IDENTIFIED 11 TRIALS (800 PARTICIPANTS) AND TWO ONGOING STUDIES. STYLE AND DURATION OF YOGA DIFFERED BETWEEN TRIALS. HALF OF THE PARTICIPANTS RECRUITED TO THE STUDIES WERE AT HIGH RISK OF CVD. MOST OF STUDIES WERE AT RISK OF PERFORMANCE BIAS, WITH INADEQUATE DETAILS REPORTED IN MANY OF THEM TO JUDGE THE RISK OF SELECTION BIAS.NO STUDY REPORTED CARDIOVASCULAR MORTALITY, ALL-CAUSE MORTALITY OR NON-FATAL EVENTS, AND MOST STUDIES WERE SMALL AND SHORT-TERM. THERE WAS SUBSTANTIAL HETEROGENEITY BETWEEN STUDIES MAKING IT IMPOSSIBLE TO COMBINE STUDIES STATISTICALLY FOR SYSTOLIC BLOOD PRESSURE AND TOTAL CHOLESTEROL. YOGA WAS FOUND TO PRODUCE REDUCTIONS IN DIASTOLIC BLOOD PRESSURE (MEAN DIFFERENCE (MD) -2.90 MMHG, 95% CONFIDENCE INTERVAL (CI) -4.52 TO -1.28), WHICH WAS STABLE ON SENSITIVITY ANALYSIS, TRIGLYCERIDES (MD -0.27 MMOL/L, 95% CI -0.44 TO -0.11) AND HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL (MD 0.08 MMOL/L, 95% CI 0.02 TO 0.14). HOWEVER, THE CONTRIBUTING STUDIES WERE SMALL, SHORT-TERM AND AT UNCLEAR OR HIGH RISK OF BIAS. THERE WAS NO CLEAR EVIDENCE OF A DIFFERENCE BETWEEN GROUPS FOR LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL (MD -0.09 MMOL/L, 95% CI -0.48 TO 0.30), ALTHOUGH THERE WAS MODERATE STATISTICAL HETEROGENEITY. ADVERSE EVENTS, OCCURRENCE OF TYPE 2 DIABETES AND COSTS WERE NOT REPORTED IN ANY OF THE INCLUDED STUDIES. QUALITY OF LIFE WAS MEASURED IN THREE TRIALS BUT THE RESULTS WERE INCONCLUSIVE. AUTHORS' CONCLUSIONS: THE LIMITED EVIDENCE COMES FROM SMALL, SHORT-TERM, LOW-QUALITY STUDIES. THERE IS SOME EVIDENCE THAT YOGA HAS FAVOURABLE EFFECTS ON DIASTOLIC BLOOD PRESSURE, HDL CHOLESTEROL AND TRIGLYCERIDES, AND UNCERTAIN EFFECTS ON LDL CHOLESTEROL. THESE RESULTS SHOULD BE CONSIDERED AS EXPLORATORY AND INTERPRETED WITH CAUTION. 2014 3 1064 45 EFFECTS OF YOGA ON IMMUNE FUNCTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. OBJECTIVE: THIS SYSTEMATIC REVIEW ATTEMPTS TO CONFIRM THE ADDED EVIDENCE TO ASSESS THE EFFECT OF YOGA ON IMMUNE FUNCTION. METHODS: THE COCHRANE LIBRARY, EMBASE, PSYCINFO, PUBMED, AND WEB OF SCIENCE ELECTRONIC DATABASES WERE SEARCHED ACCORDING TO THE PRISRMA METHOD TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE IMMUNOLOGICAL EFFECTS OF YOGA PUBLISHED IN THE ENGLISH LANGUAGE FROM JANUARY 1, 2017, TO DECEMBER 31, 2020. THIS REVIEW COULD ONLY BE DESCRIPTIVELY SUMMARIZED BECAUSE OF HETEROGENEITY OF THE INCLUDED RCTS. RESULTS: ELEVEN POTENTIAL TRIALS WERE IDENTIFIED AND INCLUDED IN THIS REVIEW. QUALITY APPRAISAL OF INCLUDED TRIALS RANGED FROM 3 FOR UNCLEAR RISK OF BIAS AND 8 FOR HIGH RISK OF BIAS. THERE IS EVIDENCE FROM 11 RCTS THAT YOGA MAY HAVE FAVORABLE EFFECTS FOR REDUCING THE LEVELS OF ANTI-INFLAMMATORY MARKERS. CONCLUSIONS: YOGA MAY BE USED AS A COMPLEMENTARY INTERVENTION FOR CLINICAL POPULATIONS OR HEALTHY INDIVIDUALS. 2021 4 1055 40 EFFECTS OF YOGA ON CHRONIC NECK PAIN: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. [PURPOSE] THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF CHRONIC NECK PAIN. [SUBJECTS AND METHODS] FIVE ELECTRONIC DATABASES WERE SEARCHED TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA INTERVENTION ON CHRONIC NECK PAIN. THE TRIALS WERE PUBLISHED IN THE ENGLISH LANGUAGE BETWEEN JANUARY 1966 AND DECEMBER 2015. THE COCHRANE RISK OF BIAS TOOL WAS USED TO ASSESS THE QUALITY OF THE TRIALS. [RESULTS] THREE TRIALS WERE IDENTIFIED AND INCLUDED IN THIS REVIEW. A CRITICAL APPRAISAL WAS PERFORMED ON THE TRIALS, AND THE RESULT INDICATED A HIGH RISK OF BIAS. A NARRATIVE DESCRIPTION WAS PROCESSED BECAUSE OF THE SMALL NUMBER OF RCTS. NECK PAIN INTENSITY AND FUNCTIONAL DISABILITY WERE SIGNIFICANTLY LOWER IN THE YOGA GROUPS THAN IN THE CONTROL GROUPS. [CONCLUSION] EVIDENCE FROM THE 3 RANDOMLY CONTROLLED TRIALS SHOWS THAT YOGA MAY BE BENEFICIAL FOR CHRONIC NECK PAIN. THE LOW-QUALITY RESULT OF THE CRITICAL APPRAISAL AND THE SMALL NUMBER OF TRIALS SUGGEST THAT HIGH-QUALITY RCTS ARE REQUIRED TO EXAMINE FURTHER THE EFFECTS OF YOGA INTERVENTION ON CHRONIC NECK PAIN RELIEF. 2016 5 477 62 CLINICAL APPLICATIONS OF YOGA FOR THE PEDIATRIC POPULATION: A SYSTEMATIC REVIEW. OBJECTIVE: THE AIM OF THIS STUDY WAS TO EVALUATE THE EVIDENCE FOR CLINICAL APPLICATIONS OF YOGA AMONG THE PEDIATRIC POPULATION. METHODS: WE CONDUCTED AN ELECTRONIC LITERATURE SEARCH INCLUDING CINAHL, COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), EMBASE, MEDLINE, PSYCINFO, AND MANUAL SEARCH OF RETRIEVED ARTICLES FROM INCEPTION OF EACH DATABASE UNTIL DECEMBER 2008. RANDOMIZED CONTROLLED TRIALS (RCTS) AND NONRANDOMIZED CONTROLLED TRIALS (NRCTS) WERE SELECTED THAT INCLUDED YOGA OR YOGA-BASED INTERVENTIONS FOR INDIVIDUALS AGED 0 TO 21 YEARS. DATA WERE EXTRACTED AND ARTICLES CRITICALLY REVIEWED USING A MODIFIED JADAD SCORE AND DESCRIPTIVE METHODOLOGICAL CRITERIA, WITH SUMMARIZATION IN TABLES. RESULTS: THIRTY-FOUR CONTROLLED STUDIES PUBLISHED FROM 1979 TO 2008 WERE IDENTIFIED, WITH 19 RCTS AND 15 NRCTS. MANY STUDIES WERE OF LOW METHODOLOGICAL QUALITY. CLINICAL AREAS FOR WHICH YOGA HAS BEEN STUDIED INCLUDE PHYSICAL FITNESS, CARDIORESPIRATORY EFFECTS, MOTOR SKILLS/STRENGTH, MENTAL HEALTH AND PSYCHOLOGICAL DISORDERS, BEHAVIOR AND DEVELOPMENT, IRRITABLE BOWEL SYNDROME, AND BIRTH OUTCOMES FOLLOWING PRENATAL YOGA. NO ADVERSE EVENTS WERE REPORTED IN TRIALS REVIEWED. ALTHOUGH A LARGE MAJORITY OF STUDIES WERE POSITIVE, METHODOLOGICAL LIMITATIONS SUCH AS RANDOMIZATION METHODS, WITHDRAWAL/DROPOUTS, AND DETAILS OF YOGA INTERVENTION PRECLUDE CONCLUSIVE EVIDENCE. CONCLUSIONS: THERE ARE LIMITED DATA ON THE CLINICAL APPLICATIONS OF YOGA AMONG THE PEDIATRIC POPULATION. MOST PUBLISHED CONTROLLED TRIALS WERE SUGGESTIVE OF BENEFIT, BUT RESULTS ARE PRELIMINARY BASED ON LOW QUANTITY AND QUALITY OF TRIALS. FURTHER RESEARCH OF YOGA FOR CHILDREN BY USING A HIGHER STANDARD OF METHODOLOGY AND REPORTING IS WARRANTED. 2009 6 1856 58 RANDOMISED CONTROLLED TRIALS OF YOGA INTERVENTIONS FOR WOMEN WITH BREAST CANCER: A SYSTEMATIC LITERATURE REVIEW. PURPOSE: YOGA IS INCREASINGLY USED AS A COMPLEMENTARY THERAPY TO MANAGE DISEASE AND TREATMENT-RELATED SIDE EFFECTS IN PATIENTS WITH CANCER AND HAS RESULTED IN AN INCREASE IN THE NUMBER OF STUDIES EXPLORING THE EFFECTIVENESS OF YOGA INTERVENTIONS. THIS SYSTEMATIC REVIEW EXAMINES WHETHER YOGA INTERVENTIONS PROVIDE ANY MEASURABLE BENEFIT, BOTH PHYSICALLY AND PSYCHOLOGICALLY, FOR WOMEN WITH BREAST CANCER. THE RESULTS WILL INFORM FUTURE RESEARCH IN THIS FIELD AND ADVANCE THE DEVELOPMENT OF YOGA PROGRAMMES. METHODS: WE PERFORMED ELECTRONIC SEARCHES OF MEDLINE, PSYCHINFO, THE COCHRANE LIBRARY, EMBASE, CINAHL, AMED, WEB OF SCIENCE AND SCOPUS FOR ARTICLES PUBLISHED UP TO JUNE 2012. ONLY RANDOMISED CONTROLLED TRIALS (RCTS) WERE INCLUDED AND METHODOLOGICAL QUALITY RATING SCORES WERE DETERMINED USING THE PEDRO (PHYSIOTHERAPY EVIDENCE DATABASE) SCALE. RESULTS: ONE HUNDRED THIRTY-TWO STUDIES WERE IDENTIFIED THROUGH A SYSTEMATIC SEARCH OF EIGHT ELECTRONIC DATABASES. ONLY PUBLISHED MANUSCRIPTS THAT EMPLOYED A RCT DESIGN WERE INCLUDED (N = 18). THE SAMPLE SIZES FOR THESE STUDIES VARIED WIDELY FROM 18 TO 164 PARTICIPANTS AND THE ASSOCIATED PEDRO SCORES RANGED FROM 1 (POOR) TO 8 (GOOD). ALL 18 STUDIES REPORTED POSITIVE EFFECTS FOR TREATMENT-RELATED SIDE EFFECTS IN FAVOUR OF THE YOGA INTERVENTIONS, WITH THE GREATEST IMPACT ON GLOBAL QUALITY OF LIFE (QOL) SCORES AND EMOTIONAL WELL-BEING. CONCLUSION: RESULTS FROM THE FEW RCTS SUGGEST THERE IS MODERATE TO GOOD EVIDENCE THAT YOGA MAY BE A USEFUL PRACTICE FOR WOMEN RECOVERING FROM BREAST CANCER TREATMENTS. LARGE-SCALE RCTS USING OBJECTIVE MEASURES AND PATIENT-REPORTED OUTCOMES WITH LONG-TERM FOLLOW-UP ARE NEEDED TO SUBSTANTIATE WHETHER THE BENEFITS ARE TRUE AND SUSTAINABLE. 2012 7 2569 54 YOGA FOR DEPRESSION: THE RESEARCH EVIDENCE. BACKGROUND: YOGA-BASED INTERVENTIONS MAY PROVE TO BE AN ATTRACTIVE OPTION FOR THE TREATMENT OF DEPRESSION. THE AIM OF THIS STUDY IS TO SYSTEMATICALLY REVIEW THE RESEARCH EVIDENCE ON THE EFFECTIVENESS OF YOGA FOR THIS INDICATION. METHODS: SEARCHES OF THE MAJOR BIOMEDICAL DATABASES INCLUDING MEDLINE, EMBASE, CLNAHL, PSYCINFO AND THE COCHRANE LIBRARY WERE CONDUCTED. SPECIALIST COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND THE INDMED DATABASES WERE ALSO SEARCHED AND EFFORTS MADE TO IDENTIFY UNPUBLISHED AND ONGOING RESEARCH. SEARCHES WERE CONDUCTED BETWEEN JANUARY AND JUNE 2004. RELEVANT RESEARCH WAS CATEGORISED BY STUDY TYPE AND APPRAISED. CLINICAL COMMENTARIES WERE OBTAINED FOR STUDIES REPORTING CLINICAL OUTCOMES. RESULTS: FIVE RANDOMISED CONTROLLED TRIALS WERE LOCATED, EACH OF WHICH UTILISED DIFFERENT FORMS OF YOGA INTERVENTIONS AND IN WHICH THE SEVERITY OF THE CONDITION RANGED FROM MILD TO SEVERE. ALL TRIALS REPORTED POSITIVE FINDINGS BUT METHODOLOGICAL DETAILS SUCH AS METHOD OF RANDOMISATION, COMPLIANCE AND ATTRITION RATES WERE MISSING. NO ADVERSE EFFECTS WERE REPORTED WITH THE EXCEPTION OF FATIGUE AND BREATHLESSNESS IN PARTICIPANTS IN ONE STUDY. LIMITATIONS: NO LANGUAGE RESTRICTIONS WERE IMPOSED ON THE SEARCHES CONDUCTED BUT NO SEARCHES OF DATABASES IN LANGUAGES OTHER THAN ENGLISH WERE INCLUDED. CONCLUSIONS: OVERALL, THE INITIAL INDICATIONS ARE OF POTENTIALLY BENEFICIAL EFFECTS OF YOGA INTERVENTIONS ON DEPRESSIVE DISORDERS. VARIATION IN INTERVENTIONS, SEVERITY AND REPORTING OF TRIAL METHODOLOGY SUGGESTS THAT THE FINDINGS MUST BE INTERPRETED WITH CAUTION. SEVERAL OF THE INTERVENTIONS MAY NOT BE FEASIBLE IN THOSE WITH REDUCED OR IMPAIRED MOBILITY. NEVERTHELESS, FURTHER INVESTIGATION OF YOGA AS A THERAPEUTIC INTERVENTION IS WARRANTED. 2005 8 2573 57 YOGA FOR ESSENTIAL HYPERTENSION: A SYSTEMATIC REVIEW. BACKGROUND: YOGA IS THOUGHT TO BE EFFECTIVE FOR HEALTH CONDITIONS. THE ARTICLE AIMS TO ASSESS THE CURRENT CLINICAL EVIDENCE OF YOGA FOR ESSENTIAL HYPERTENSION (EH). STRATEGY: MEDLINE, EMBASE, AND THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL) IN THE COCHRANE LIBRARY WERE SEARCHED UNTIL JUNE, 2013. WE INCLUDED RANDOMIZED CLINICAL TRIALS TESTING YOGA AGAINST CONVENTIONAL THERAPY, YOGA VERSUS NO TREATMENT, YOGA COMBINED WITH CONVENTIONAL THERAPY VERSUS CONVENTIONAL THERAPY OR CONVENTIONAL THERAPY COMBINED WITH BREATH AWARENESS. STUDY SELECTION, DATA EXTRACTION, QUALITY ASSESSMENT, AND DATA ANALYSES WERE CONDUCTED ACCORDING TO THE COCHRANE STANDARDS. RESULTS: A TOTAL OF 6 STUDIES (INVOLVING 386 PATIENTS) WERE INCLUDED. THE METHODOLOGICAL QUALITY OF THE INCLUDED TRIALS WAS EVALUATED AS GENERALLY LOW. A TOTAL OF 6 RCTS MET ALL THE INCLUSION CRITERIA. 4 OF THEM COMPARED YOGA PLUS CONVENTIONAL THERAPY WITH CONVENTIONAL THERAPY. 1 RCT DESCRIBED YOGA COMBINED WITH CONVENTIONAL THERAPY VERSUS CONVENTIONAL THERAPY COMBINED WITH BREATH AWARENESS. 2 RCT TESTED THE EFFECT OF YOGA VERSUS CONVENTIONAL THERAPY ALONE. 1 RCT DESCRIBED YOGA COMPARED TO NO TREATMENT. ONLY ONE TRIAL REPORTED ADVERSE EVENTS WITHOUT DETAILS, THE SAFETY OF YOGA IS STILL UNCERTAIN. CONCLUSIONS: THERE IS SOME ENCOURAGING EVIDENCE OF YOGA FOR LOWERING SBP AND DBP. HOWEVER, DUE TO LOW METHODOLOGICAL QUALITY OF THESE IDENTIFIED TRIALS, A DEFINITE CONCLUSION ABOUT THE EFFICACY AND SAFETY OF YOGA ON EH CANNOT BE DRAWN FROM THIS REVIEW. THEREFORE, FURTHER THOROUGH INVESTIGATION, LARGE-SCALE, PROPER STUDY DESIGNED, RANDOMIZED TRIALS OF YOGA FOR HYPERTENSION WILL BE REQUIRED TO JUSTIFY THE EFFECTS REPORTED HERE. 2013 9 2742 47 YOGA PRACTICE FOR THE MANAGEMENT OF TYPE II DIABETES MELLITUS IN ADULTS: A SYSTEMATIC REVIEW. THE EFFECT OF PRACTICING YOGA FOR THE MANAGEMENT OF TYPE II DIABETES WAS ASSESSED IN THIS SYSTEMATIC REVIEW THROUGH SEARCHING RELATED ELECTRONIC DATABASES AND THE GREY LITERATURE TO THE END OF MAY 2007 USING OVID. ALL RANDOMIZED CONTROLLED CLINICAL TRIALS (RCTS) COMPARING YOGA PRACTICE WITH OTHER TYPE OF INTERVENTION OR WITH REGULAR PRACTICE OR BOTH, WERE INCLUDED REGARDLESS OF LANGUAGE OR TYPE OF PUBLICATION. EACH STUDY WAS ASSESSED FOR QUALITY BY TWO INDEPENDENT REVIEWERS. MEAN DIFFERENCE WAS USED FOR SUMMARIZING THE EFFECT OF EACH STUDY OUTCOMES WITH 95% CONFIDENCE INTERVALS. POOLING OF THE STUDIES DID NOT TAKE PLACE DUE TO THE WIDE CLINICAL VARIATION BETWEEN THE STUDIES. PUBLICATION BIAS WAS ASSESSED BY STATISTICAL METHODS. FIVE TRIALS WITH 363 PARTICIPANTS MET THE INCLUSION CRITERIA WITH MEDIUM TO HIGH RISK OF BIAS AND DIFFERENT INTERVENTION CHARACTERISTICS. THE STUDIES' RESULTS SHOW IMPROVEMENT IN OUTCOMES AMONG PATIENTS WITH DIABETES TYPE II. THESE IMPROVEMENTS WERE MAINLY AMONG SHORT TERM OR IMMEDIATE DIABETES OUTCOMES AND NOT ALL WERE STATISTICALLY SIGNIFICANT. THE RESULTS WERE INCONCLUSIVE AND NOT SIGNIFICANT FOR THE LONG-TERM OUTCOMES. NO ADVERSE EFFECTS WERE REPORTED IN ANY OF THE INCLUDED STUDIES. SHORT-TERM BENEFITS FOR PATIENTS WITH DIABETES MAY BE ACHIEVED FROM PRACTICING YOGA. FURTHER RESEARCH IS NEEDED IN THIS AREA. FACTORS LIKE QUALITY OF THE TRIALS AND OTHER METHODOLOGICAL ISSUES SHOULD BE IMPROVED BY LARGE RANDOMIZED CONTROL TRIALS WITH ALLOCATION CONCEALMENT TO ASSESS THE EFFECTIVENESS OF YOGA ON DIABETES TYPE II. A DEFINITIVE RECOMMENDATION FOR PHYSICIANS TO ENCOURAGE THEIR PATIENTS TO PRACTICE YOGA CANNOT BE REACHED AT PRESENT. 2010 10 2543 89 YOGA FOR ASTHMA. BACKGROUND: ASTHMA IS A COMMON CHRONIC INFLAMMATORY DISORDER AFFECTING ABOUT 300 MILLION PEOPLE WORLDWIDE. AS A HOLISTIC THERAPY, YOGA HAS THE POTENTIAL TO RELIEVE BOTH THE PHYSICAL AND PSYCHOLOGICAL SUFFERING OF PEOPLE WITH ASTHMA, AND ITS POPULARITY HAS EXPANDED GLOBALLY. A NUMBER OF CLINICAL TRIALS HAVE BEEN CARRIED OUT TO EVALUATE THE EFFECTS OF YOGA PRACTICE, WITH INCONSISTENT RESULTS. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA IN PEOPLE WITH ASTHMA. SEARCH METHODS: WE SYSTEMATICALLY SEARCHED THE COCHRANE AIRWAYS GROUP REGISTER OF TRIALS, WHICH IS DERIVED FROM SYSTEMATIC SEARCHES OF BIBLIOGRAPHIC DATABASES INCLUDING THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED, AND PSYCINFO, AND HANDSEARCHING OF RESPIRATORY JOURNALS AND MEETING ABSTRACTS. WE ALSO SEARCHED PEDRO. WE SEARCHED CLINICALTRIALS.GOV AND THE WHO ICTRP SEARCH PORTAL. WE SEARCHED ALL DATABASES FROM THEIR INCEPTION TO 22 JULY 2015, AND USED NO RESTRICTION ON LANGUAGE OF PUBLICATION. WE CHECKED THE REFERENCE LISTS OF ELIGIBLE STUDIES AND RELEVANT REVIEW ARTICLES FOR ADDITIONAL STUDIES. WE ATTEMPTED TO CONTACT INVESTIGATORS OF ELIGIBLE STUDIES AND EXPERTS IN THE FIELD TO LEARN OF OTHER PUBLISHED AND UNPUBLISHED STUDIES. SELECTION CRITERIA: WE INCLUDED RANDOMISED CONTROLLED TRIALS (RCTS) THAT COMPARED YOGA WITH USUAL CARE (OR NO INTERVENTION) OR SHAM INTERVENTION IN PEOPLE WITH ASTHMA AND REPORTED AT LEAST ONE OF THE FOLLOWING OUTCOMES: QUALITY OF LIFE, ASTHMA SYMPTOM SCORE, ASTHMA CONTROL, LUNG FUNCTION MEASURES, ASTHMA MEDICATION USAGE, AND ADVERSE EVENTS. DATA COLLECTION AND ANALYSIS: WE EXTRACTED BIBLIOGRAPHIC INFORMATION, CHARACTERISTICS OF PARTICIPANTS, CHARACTERISTICS OF INTERVENTIONS AND CONTROLS, CHARACTERISTICS OF METHODOLOGY, AND RESULTS FOR THE OUTCOMES OF OUR INTEREST FROM ELIGIBLE STUDIES. FOR CONTINUOUS OUTCOMES, WE USED MEAN DIFFERENCE (MD) WITH 95% CONFIDENCE INTERVAL (CI) TO DENOTE THE TREATMENT EFFECTS, IF THE OUTCOMES WERE MEASURED BY THE SAME SCALE ACROSS STUDIES. ALTERNATIVELY, IF THE OUTCOMES WERE MEASURED BY DIFFERENT SCALES ACROSS STUDIES, WE USED STANDARDISED MEAN DIFFERENCE (SMD) WITH 95% CI. FOR DICHOTOMOUS OUTCOMES, WE USED RISK RATIO (RR) WITH 95% CI TO MEASURE THE TREATMENT EFFECTS. WE PERFORMED META-ANALYSIS WITH REVIEW MANAGER 5.3. WE USED THE FIXED-EFFECT MODEL TO POOL THE DATA, UNLESS THERE WAS SUBSTANTIAL HETEROGENEITY AMONG STUDIES, IN WHICH CASE WE USED THE RANDOM-EFFECTS MODEL INSTEAD. FOR OUTCOMES INAPPROPRIATE OR IMPOSSIBLE TO POOL QUANTITATIVELY, WE CONDUCTED A DESCRIPTIVE ANALYSIS AND SUMMARISED THE FINDINGS NARRATIVELY. MAIN RESULTS: WE INCLUDED 15 RCTS WITH A TOTAL OF 1048 PARTICIPANTS. MOST OF THE TRIALS WERE CONDUCTED IN INDIA, FOLLOWED BY EUROPE AND THE UNITED STATES. THE MAJORITY OF PARTICIPANTS WERE ADULTS OF BOTH SEXES WITH MILD TO MODERATE ASTHMA FOR SIX MONTHS TO MORE THAN 23 YEARS. FIVE STUDIES INCLUDED YOGA BREATHING ALONE, WHILE THE OTHER STUDIES ASSESSED YOGA INTERVENTIONS THAT INCLUDED BREATHING, POSTURE, AND MEDITATION. INTERVENTIONS LASTED FROM TWO WEEKS TO 54 MONTHS, FOR NO MORE THAN SIX MONTHS IN THE MAJORITY OF STUDIES. THE RISK OF BIAS WAS LOW ACROSS ALL DOMAINS IN ONE STUDY AND UNCLEAR OR HIGH IN AT LEAST ONE DOMAIN FOR THE REMAINDER.THERE WAS SOME EVIDENCE THAT YOGA MAY IMPROVE QUALITY OF LIFE (MD IN ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) SCORE PER ITEM 0.57 UNITS ON A 7-POINT SCALE, 95% CI 0.37 TO 0.77; 5 STUDIES; 375 PARTICIPANTS), IMPROVE SYMPTOMS (SMD 0.37, 95% CI 0.09 TO 0.65; 3 STUDIES; 243 PARTICIPANTS), AND REDUCE MEDICATION USAGE (RR 5.35, 95% CI 1.29 TO 22.11; 2 STUDIES) IN PEOPLE WITH ASTHMA. THE MD FOR AQLQ SCORE EXCEEDED THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) OF 0.5, BUT WHETHER THE MEAN CHANGES EXCEEDED THE MCID FOR ASTHMA SYMPTOMS IS UNCERTAIN DUE TO THE LACK OF AN ESTABLISHED MCID IN THE SEVERITY SCORES USED IN THE INCLUDED STUDIES. THE EFFECTS OF YOGA ON CHANGE FROM BASELINE FORCED EXPIRATORY VOLUME IN ONE SECOND (MD 0.04 LITRES, 95% CI -0.10 TO 0.19; 7 STUDIES; 340 PARTICIPANTS; I(2) = 68%) WERE NOT STATISTICALLY SIGNIFICANT. TWO STUDIES INDICATED IMPROVED ASTHMA CONTROL, BUT DUE TO VERY SIGNIFICANT HETEROGENEITY (I(2) = 98%) WE DID NOT POOL DATA. NO SERIOUS ADVERSE EVENTS ASSOCIATED WITH YOGA WERE REPORTED, BUT THE DATA ON THIS OUTCOME WAS LIMITED. AUTHORS' CONCLUSIONS: WE FOUND MODERATE-QUALITY EVIDENCE THAT YOGA PROBABLY LEADS TO SMALL IMPROVEMENTS IN QUALITY OF LIFE AND SYMPTOMS IN PEOPLE WITH ASTHMA. THERE IS MORE UNCERTAINTY ABOUT POTENTIAL ADVERSE EFFECTS OF YOGA AND ITS IMPACT ON LUNG FUNCTION AND MEDICATION USAGE. RCTS WITH A LARGE SAMPLE SIZE AND HIGH METHODOLOGICAL AND REPORTING QUALITY ARE NEEDED TO CONFIRM THE EFFECTS OF YOGA FOR ASTHMA. 2016 11 2589 46 YOGA FOR LOW BACK PAIN: A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. IT HAS BEEN SUGGESTED THAT YOGA HAS A POSITIVE EFFECT ON LOW BACK PAIN AND FUNCTION. THE OBJECTIVE OF THIS SYSTEMATIC REVIEW WAS TO ASSESS THE EFFECTIVENESS OF YOGA AS A TREATMENT OPTION FOR LOW BACK PAIN. SEVEN DATABASES WERE SEARCHED FROM THEIR INCEPTION TO MARCH 2011. RANDOMIZED CLINICAL TRIALS WERE CONSIDERED IF THEY INVESTIGATED YOGA IN PATIENTS WITH LOW BACK PAIN AND IF THEY ASSESSED PAIN AS AN OUTCOME MEASURE. THE SELECTION OF STUDIES, DATA EXTRACTION AND VALIDATION WERE PERFORMED INDEPENDENTLY BY TWO REVIEWERS. SEVEN RANDOMIZED CONTROLLED CLINICAL TRIALS (RCTS) MET THE INCLUSION CRITERIA. THEIR METHODOLOGICAL QUALITY RANGED BETWEEN 2 AND 4 ON THE JADAD SCALE. FIVE RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN LOW BACK PAIN THAN USUAL CARE, EDUCATION OR CONVENTIONAL THERAPEUTIC EXERCISES. TWO RCTS SHOWED NO BETWEEN-GROUP DIFFERENCES. IT IS CONCLUDED THAT YOGA HAS THE POTENTIAL TO ALLEVIATE LOW BACK PAIN. HOWEVER, ANY DEFINITIVE CLAIMS SHOULD BE TREATED WITH CAUTION. 2011 12 1202 42 EXERCISE, YOGA, AND TAI CHI FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER IN OUTPATIENT SETTINGS: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: EXERCISE, YOGA, AND TAI CHI ARE COMMONLY USED COMPLEMENTARY APPROACHES FOR HEALTH AND WELLNESS. THIS REVIEW AIMS TO SYNTHESIZE THE EVIDENCE FOR EXERCISE, YOGA, AND TAI CHI IN THE OUTPATIENT TREATMENT OF MAJOR DEPRESSIVE DISORDER. STUDY SELECTION: A SYSTEMATIC SEARCH OF THE OVID MEDLINE, EMBASE, PSYCINFO, AND COCHRANE DATABASES WAS CONDUCTED FOR RANDOMIZED CONTROLLED TRIALS OF EXERCISE, YOGA, AND TAI CHI FOR MAJOR DEPRESSIVE DISORDER. DATA EXTRACTION: STANDARDIZED MEAN DIFFERENCES WERE CALCULATED AND META-ANALYZED USING A RANDOM EFFECTS MULTILEVEL MODELING FRAMEWORK. HETEROGENEITY AND SUBGROUP ANALYSIS WAS CONDUCTED. RESULTS: TWENTY-FIVE STUDIES WERE INCLUDED FOR FINAL ANALYSIS (EXERCISE: 15, YOGA: 7, TAI CHI: 3). OVERALL, META-ANALYSIS SHOWED A MODERATE SIGNIFICANT CLINICAL EFFECT. HOWEVER, WHEN ONLY STUDIES (6 STUDIES) WITH THE LOWEST RISK OF BIAS WERE INCLUDED, THE OVERALL EFFECT SIZE WAS REDUCED TO LOW TO MODERATE EFFICACY. OVERALL QUALITY OF EVIDENCE WAS LOW. HETEROGENEITY AND PUBLICATION BIAS WERE HIGH. CONCLUSIONS: THE CURRENT META-ANALYSIS OF OUTPATIENT EXERCISE, YOGA, AND TAI CHI FOR TREATMENT OF MAJOR DEPRESSIVE DISORDER SUGGESTS THAT ADJUNCTIVE EXERCISE AND YOGA MAY HAVE SMALL ADDITIVE CLINICAL EFFECTS IN COMPARISON TO CONTROL FOR REDUCING DEPRESSIVE SYMPTOMS. THE EVIDENCE FOR TAI CHI IS INSUFFICIENT TO DRAW CONCLUSIONS. THE CONCERNS WITH QUALITY OF STUDIES, HIGH HETEROGENEITY, AND EVIDENCE OF PUBLICATION BIAS PRECLUDE MAKING FIRM CONCLUSIONS. 2020 13 1031 46 EFFECTS OF YOGA EXERCISES FOR HEADACHES: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS. [PURPOSE] TO ASSESS THE EVIDENCE FOR THE EFFECTIVENESS OF YOGA EXERCISES IN THE MANAGEMENT OF HEADACHES. [SUBJECTS AND METHODS] A SEARCH WAS CONDUCTED OF SIX ELECTRONIC DATABASES TO IDENTIFY RANDOMIZED CONTROLLED TRIALS (RCTS) REPORTING THE EFFECTS OF YOGIC INTERVENTION ON HEADACHES PUBLISHED IN ANY LANGUAGE BEFORE JANUARY 2015. QUALITY ASSESSMENT WAS CONDUCTED USING THE COCHRANE RISK OF BIAS TOOL. [RESULTS] ONE POTENTIAL TRIAL WAS IDENTIFIED AND INCLUDED IN THIS REVIEW. THE QUALITY CRITICAL APPRAISAL INDICATED A MODERATE RISK OF BIAS. THE AVAILABLE DATA COULD ONLY BE INCLUDED AS A NARRATIVE DESCRIPTION. HEADACHE INTENSITY AND FREQUENCY, ANXIETY AND DEPRESSION SCORES, AND SYMPTOMATIC MEDICATION USE WERE SIGNIFICANTLY LOWER IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. [CONCLUSION] THERE IS EVIDENCE FROM ONE RCT THAT YOGA EXERCISES MAY BE BENEFICIAL FOR HEADACHES. HOWEVER, THE FINDINGS SHOULD BE INTERPRETED WITH CAUTION DUE TO THE SMALL NUMBER OF RCTS. THEREFORE, FURTHER RIGOROUS METHODOLOGICAL AND HIGH QUALITY RCTS ARE REQUIRED TO INVESTIGATE THE HYPOTHESIS THAT YOGA EXERCISES ALLEVIATE HEADACHES, AND TO CONFIRM AND FURTHER COMPREHEND THE EFFECTS OF STANDARDIZED YOGA PROGRAMS ON HEADACHES. 2015 14 1519 54 IS YOGA EFFECTIVE FOR PAIN? A SYSTEMATIC REVIEW OF RANDOMIZED CLINICAL TRIALS. OBJECTIVE: THE OBJECTIVE OF THIS SYSTEMATIC REVIEW WAS TO ASSESS THE EFFECTIVENESS OF YOGA AS A TREATMENT OPTION FOR ANY TYPE OF PAIN. METHOD: SEVEN DATABASES WERE SEARCHED FROM THEIR INCEPTION TO FEBRUARY 2011. RANDOMIZED CLINICAL TRIALS WERE CONSIDERED IF THEY INVESTIGATED YOGA IN PATIENTS WITH ANY TYPE OF PAIN AND IF THEY ASSESSED PAIN AS A PRIMARY OUTCOME MEASURE. THE 5-POINT JADAD SCALE WAS USED TO ASSESS METHODOLOGICAL QUALITY OF STUDIES. THE SELECTION OF STUDIES, DATA EXTRACTION AND QUALITY ASSESSMENT WERE PERFORMED INDEPENDENTLY BY TWO REVIEWERS. RESULTS: TEN RANDOMIZED CLINICAL TRIALS (RCTS) MET THE INCLUSION CRITERIA. THEIR METHODOLOGICAL QUALITY RANGED BETWEEN 1 AND 4 ON THE JADAD SCALE. NINE RCTS SUGGESTED THAT YOGA LEADS TO A SIGNIFICANTLY GREATER REDUCTION IN PAIN THAN VARIOUS CONTROL INTERVENTIONS SUCH AS STANDARD CARE, SELF CARE, THERAPEUTIC EXERCISES, RELAXING YOGA, TOUCH AND MANIPULATION, OR NO INTERVENTION. ONE RCT FAILED TO PROVIDE BETWEEN GROUP DIFFERENCES IN PAIN SCORES. CONCLUSIONS: IT IS CONCLUDED THAT YOGA HAS THE POTENTIAL FOR ALLEVIATING PAIN. HOWEVER, DEFINITIVE JUDGMENTS ARE NOT POSSIBLE. 2011 15 2617 63 YOGA FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: YOGA HAS BEEN WIDELY PRACTICED AND HAS RECENTLY SHOWN BENEFITS IN PATIENTS WITH CORONARY HEART DISEASE (CHD), HOWEVER, EVIDENCE IS INCONSISTENT. METHODS: WE CONDUCTED A SYSTEMATIC REVIEW AND META-ANALYSIS BY SEARCHING PUBMED/MEDLINE, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), EMBASE AND WEB OF SCIENCE FROM INCEPTION TO MAY 31, 2020 FOR RANDOMISED CONTROLLED TRIALS (RCTS) COMPARING YOGA WITH USUAL CARE OR NON-PHARMACOLOGICAL INTERVENTIONS IN PATIENTS WITH CHD. THE PRIMARY OUTCOMES WERE ALL-CAUSE MORTALITY AND HEALTH RELATED QUALITY OF LIFE (HR-QOL). SECONDARY OUTCOMES WERE A COMPOSITE CARDIOVASCULAR OUTCOME, EXERCISE CAPACITY AND CARDIOVASCULAR RISK FACTORS (BLOOD PRESSURE, LIPID PROFILES AND BODY MASS INDEX). RESULTS: SEVEN RCTS WITH A TOTAL OF 4671 PARTICIPANTS WERE INCLUDED. SIX RCTS COMPARED YOGA WITH USUAL CARE AND ONE COMPARED YOGA WITH DESIGNED EXERCISE. THE MEAN AGE OF THE PARTICIPANTS RANGED FROM 51.0-60.7 YEARS AND THE MAJORITY OF THEM WERE MEN (85.4 %). POOLED RESULTS SHOWED THAT COMPARED WITH USUAL CARE, YOGA HAD NO EFFECT ON ALL-CAUSE MORTALITY (RR, 1.02; 95 % CI, 0.75-1.39), BUT IT SIGNIFICANTLY IMPROVED HR-QOL (SMD, 0.07; 95 % CI, 0.01 - 0.14). A NON-SIGNIFICANT REDUCTION OF THE COMPOSITE CARDIOVASCULAR OUTCOME WAS OBSERVED (133 VS. 154; RR, 0.63; 95 % CI, 0.15-2.59). SERUM LEVEL OF TRIGLYCERIDE AND HIGH DENSITY LIPOPROTEIN CHOLESTEROL, BLOOD PRESSURE AND BODY MASS INDEX WERE ALSO SIGNIFICANTLY IMPROVED. THE STUDY COMPARING YOGA WITH CONTROL EXERCISE ALSO REPORTED SIGNIFICANTLY BETTER EFFECTS OF YOGA ON HR-QOL (85.75 VS. 75.24, P < 0.001). NO SEVERE ADVERSE EVENTS RELATED TO YOGA WERE REPORTED. CONCLUSIONS: YOGA MIGHT BE A PROMISING ALTERNATIVE FOR PATIENTS WITH CHD AS IT IS ASSOCIATED WITH IMPROVED QUALITY OF LIFE, LESS NUMBER OF COMPOSITE CARDIOVASCULAR EVENTS, AND IMPROVED CARDIOVASCULAR RISK FACTORS. 2021 16 2689 49 YOGA IN THE WORKPLACE AND HEALTH OUTCOMES: A SYSTEMATIC REVIEW. BACKGROUND: HEALTH PROMOTION IN THE WORKPLACE IS INTENDED TO ENHANCE EMPLOYEE HEALTH AND WELL-BEING. YOGA PROGRAMMES ARE EASY TO IMPLEMENT AND HAVE BEEN EFFECTIVE IN THE MANAGEMENT OF VARIOUS HEALTH CONDITIONS. AIMS: TO ASSESS THE EVIDENCE REGARDING THE EFFECTIVENESS OF YOGA PROGRAMMES AT WORK. METHODS: A SEARCH OF ELECTRONIC DATABASES OF PUBLISHED STUDIES UP UNTIL THE 1ST OF APRIL 2017. INCLUSION CRITERIA FOR THE SYSTEMATIC REVIEW WERE RANDOMIZED CONTROLLED TRIALS OF ADULT EMPLOYEES AND YOGA IN THE WORKPLACE. QUALITY APPRAISAL WAS CARRIED OUT USING THE COCHRANE COLLABORATION'S TOOL FOR ASSESSING RISK OF BIAS IN RANDOMIZED TRIALS. RESULTS: OF 1343 PAPERS IDENTIFIED, 13 STUDIES MET THE INCLUSION CRITERIA. NINE OUT OF 13 TRIALS WERE CLASSIFIED AS HAVING AN UNCLEAR RISK OF BIAS. THE OVERALL EFFECTS OF YOGA ON MENTAL HEALTH OUTCOMES WERE BENEFICIAL, MAINLY ON STRESS. MOST OF THE CARDIOVASCULAR ENDPOINTS SHOWED NO DIFFERENCES BETWEEN YOGA AND CONTROLS. OTHER OUTCOMES REPORTED POSITIVE EFFECTS OF YOGA OR NO CHANGE. CONCLUSIONS: THE FINDINGS OF THIS STUDY SUGGEST THAT YOGA HAS A POSITIVE EFFECT ON HEALTH IN THE WORKPLACE, PARTICULARLY IN REDUCING STRESS, AND NO NEGATIVE EFFECTS WERE REPORTED IN ANY OF THE RANDOMIZED CONTROLLED TRIALS. FURTHER LARGER STUDIES ARE REQUIRED TO CONFIRM THIS. 2019 17 1910 60 RISK INDICES ASSOCIATED WITH THE INSULIN RESISTANCE SYNDROME, CARDIOVASCULAR DISEASE, AND POSSIBLE PROTECTION WITH YOGA: A SYSTEMATIC REVIEW. OBJECTIVE: TO CONDUCT A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE REGARDING THE EFFECTS OF YOGA, A PROMISING MIND-BODY THERAPY, ON SPECIFIC ANTHROPOMETRIC AND PHYSIOLOGIC INDICES OF CARDIOVASCULAR DISEASE (CVD) RISK AND ON RELATED CLINICAL ENDPOINTS. METHODS: WE PERFORMED A LITERATURE SEARCH USING 4 COMPUTERIZED ENGLISH AND INDIAN SCIENTIFIC DATABASES. THE SEARCH WAS RESTRICTED TO ORIGINAL STUDIES (1970 TO 2004) EVALUATING THE EFFECTS OF YOGA ON CVD OR INDICES OF CVD RISK ASSOCIATED WITH THE INSULIN RESISTANCE SYNDROME (IRS). RANDOMIZED CONTROLLED TRIALS (RCTS), NONRANDOMIZED CONTROLLED TRIALS, UNCONTROLLED (PRE AND POST) CLINICAL TRIALS, AND CROSS-SECTIONAL (OBSERVATIONAL) STUDIES WERE INCLUDED IF THEY MET SPECIFIC CRITERIA. DATA WERE EXTRACTED REGARDING STUDY DESIGN, SETTING, POPULATION SIZE AND CHARACTERISTICS, INTERVENTION TYPE AND DURATION, COMPARISON GROUP OR CONDITION, OUTCOME ASSESSMENT, DATA ANALYSIS AND PRESENTATION, FOLLOW-UP, AND KEY RESULTS, AND THE QUALITY OF EACH STUDY WAS EVALUATED ACCORDING TO SPECIFIC PREDETERMINED CRITERIA. RESULTS: WE IDENTIFIED 70 ELIGIBLE STUDIES, INCLUDING 1 OBSERVATIONAL STUDY, 26 UNCONTROLLED CLINICAL TRIALS, 21 NONRANDOMIZED CONTROLLED CLINICAL TRIALS, AND 22 RCTS. TOGETHER, THE REPORTED RESULTS OF THESE STUDIES INDICATE BENEFICIAL CHANGES OVERALL IN SEVERAL IRS-RELATED INDICES OF CVD RISK, INCLUDING GLUCOSE TOLERANCE AND INSULIN SENSITIVITY, LIPID PROFILES, ANTHROPOMETRIC CHARACTERISTICS, BLOOD PRESSURE, OXIDATIVE STRESS, COAGULATION PROFILES, SYMPATHETIC ACTIVATION, AND CARDIOVAGAL FUNCTION, AS WELL AS IMPROVEMENT IN SEVERAL CLINICAL ENDPOINTS. CONCLUSIONS: COLLECTIVELY, THESE STUDIES SUGGEST THAT YOGA MAY REDUCE MANY IRS-RELATED RISK FACTORS FOR CVD, MAY IMPROVE CLINICAL OUTCOMES, AND MAY AID IN THE MANAGEMENT OF CVD AND OTHER IRS-RELATED CONDITIONS. HOWEVER, THE METHODOLOGIC AND OTHER LIMITATIONS CHARACTERIZING MOST OF THESE STUDIES PRECLUDE DRAWING FIRM CONCLUSIONS. ADDITIONAL HIGH QUALITY RCTS ARE NEEDED TO CONFIRM AND FURTHER ELUCIDATE THE EFFECTS OF STANDARDIZED YOGA PROGRAMS ON SPECIFIC INDICES OF CVD RISK AND RELATED CLINICAL ENDPOINTS. 2005 18 590 55 DETERMINING THE POTENTIAL BENEFITS OF YOGA IN CHRONIC STROKE CARE: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND: SURVIVORS OF STROKE HAVE LONG-TERM PHYSICAL AND PSYCHOLOGICAL CONSEQUENCES THAT IMPACT THEIR QUALITY OF LIFE. FEW INTERVENTIONS ARE AVAILABLE IN THE COMMUNITY TO ADDRESS THESE PROBLEMS. YOGA, A TYPE OF MINDFULNESS-BASED INTERVENTION, IS SHOWN TO BE EFFECTIVE IN PEOPLE WITH OTHER CHRONIC ILLNESSES AND MAY HAVE THE POTENTIAL TO ADDRESS MANY OF THE PROBLEMS REPORTED BY SURVIVORS OF STROKE. OBJECTIVES: TO DATE ONLY NARRATIVE REVIEWS HAVE BEEN PUBLISHED. WE SOUGHT TO PERFORM, THE FIRST SYSTEMATIC REVIEW WITH META-ANALYSES OF RANDOMIZED CONTROLLED TRIALS (RCTS) THAT INVESTIGATED YOGA FOR ITS POTENTIAL BENEFIT FOR CHRONIC SURVIVORS OF STROKE. METHODS: OVID MEDLINE, CINHAL PLUS, AMED, PUBMED, PSYCHINFO, PEDRO, COCHRANE DATABASE, SPORT DISCUSS, AND GOOGLE SCHOLAR WERE SEARCHED FOR PAPERS PUBLISHED BETWEEN JANUARY 1950 AND AUGUST 2016. REFERENCE LISTS OF INCLUDED PAPERS, REVIEW ARTICLES AND OPENGREY FOR GREY LITERATURE WERE ALSO SEARCHED. WE USED A MODIFIED COCHRANE TOOL TO EVALUATE RISK OF BIAS. THE METHODOLOGICAL QUALITY OF RCTS WAS ASSESSED USING THE GRADE APPROACH, RESULTS WERE COLLATED, AND RANDOM EFFECTS META-ANALYSES PERFORMED WHERE APPROPRIATE. RESULTS: THE SEARCH YIELDED FIVE ELIGIBLE PAPERS FROM FOUR RCTS WITH SMALL SAMPLE SIZES (N = 17-47). QUALITY OF RCTS WAS RATED AS LOW TO MODERATE. YOGA IS BENEFICIAL IN REDUCING STATE ANXIETY SYMPTOMS AND DEPRESSION IN THE INTERVENTION GROUP COMPARED TO THE CONTROL GROUP (MEAN DIFFERENCES FOR STATE ANXIETY 6.05, 95% CI:-0.02 TO 12.12; P = 0.05 AND STANDARDIZED MEAN DIFFERENCES FOR DEPRESSION: 0.50, 95% CI:-0.01 TO 1.02; P = 0.05). CONSISTENT BUT NONSIGNIFICANT IMPROVEMENTS WERE DEMONSTRATED FOR BALANCE, TRAIT ANXIETY, AND OVERALL QUALITY OF LIFE. CONCLUSIONS: YOGA MAY BE EFFECTIVE FOR AMELIORATING SOME OF THE LONG-TERM CONSEQUENCES OF STROKE. LARGE WELL-DESIGNED RCTS ARE NEEDED TO CONFIRM THESE FINDINGS. 2017 19 236 46 A SYSTEMATIC REVIEW: THE EFFECTS OF YOGA ON PREGNANCY. OBJECTIVE: A SYSTEMATIC REVIEW WAS CONDUCTED TO UPDATE AND PROVIDE A COMPREHENSIVE OVERVIEW ON THE PSYCHOLOGICAL EFFECTS OF ANTENATAL YOGA ON PREGNANCY COMPARED TO STANDARD PRENATAL CARE. STUDY DESIGN: FOUR DATABASES WERE SEARCHED USING KEYWORDS "YOGA", "PREGNANCY", "PERINATAL CARE", "PRENATAL CARE", "POSTNATAL CARE", "POSTPARTUM PERIOD", "PERIPARTUM PERIOD", "PATIENT OUTCOME ASSESSMENT", "OUTCOME ASSESSMENT", "PREGNANCY OUTCOME", "TREATMENT OUTCOME". TRIALS WERE CONSIDERED IF THEY WERE RANDOMIZED CONTROLLED TRIALS (RCTS) PUBLISHED FROM 2011 TO 2018 AND EVALUATED AN ANTENATAL YOGA INTERVENTION. ALL STUDIES WERE ASSESSED FOR RISK OF BIAS USING THE COCHRANE CRITERIA. TRIAL CHARACTERISTICS AND OUTCOMES WERE EXTRACTED AND SYNTHESIZED DESCRIPTIVELY WHERE POSSIBLE. DUE TO HETEROGENEITY, META-ANALYSIS WAS NOT POSSIBLE. RESULTS: OF THE 175 NON-DUPLICATED STUDIES, 16 MET CRITERIA FOR FULL-TEXT REVIEW. FIVE RCTS MET THE INCLUSION CRITERIA AND WERE INCLUDED IN THE SYSTEMATIC REVIEW. THE FINDINGS OF THE RCTS SUGGEST ANTENATAL YOGA MAY BE SAFE AND MAY EFFECTIVELY DECREASE STRESS LEVELS, ANXIETY SCORES, DEPRESSION SCORES, AND PAIN RESPONSE AS WELL AS INCREASING MATERNAL IMMUNITY AND EMOTIONAL-WELLBEING. CONCLUSION: YOGA APPEARS TO BE SAFE AND MAY IMPROVE PSYCHOLOGICAL AND PREGNANCY OUTCOMES. HOWEVER, DUE TO THE LIMITED NUMBER OF STUDIES, MORE HIGH-QUALITY, LARGE RCTS ARE NEEDED TO DRAW CONCLUSIONS ABOUT IMPROVEMENT IN OTHER PREGNANCY OUTCOMES. 2020 20 232 44 A SYSTEMATIC REVIEW OF YOGA FOR MAJOR DEPRESSIVE DISORDER. BACKGROUND: THE PURPOSE OF THIS REVIEW WAS TO INVESTIGATE THE EFFICACY AND SAFETY OF YOGA INTERVENTIONS IN TREATING PATIENTS WITH MAJOR DEPRESSIVE DISORDER. METHODS: MEDLINE, SCOPUS, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH DECEMBER 2016. RANDOMIZED CONTROLLED TRIALS (RCTS) COMPARING YOGA TO INACTIVE OR ACTIVE COMPARATORS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WERE ELIGIBLE. PRIMARY OUTCOMES INCLUDED REMISSION RATES AND SEVERITY OF DEPRESSION. ANXIETY AND ADVERSE EVENTS WERE SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED USING THE COCHRANE TOOL. RESULTS: SEVEN RCTS WITH 240 PARTICIPANTS WERE INCLUDED. RISK OF BIAS WAS UNCLEAR FOR MOST RCTS. COMPARED TO AEROBIC EXERCISE, NO SHORT- OR MEDIUM-TERM GROUP DIFFERENCES IN DEPRESSION SEVERITY WAS FOUND. HIGHER SHORT-TERM DEPRESSION SEVERITY WAS FOUND FOR YOGA COMPARED TO ELECTRO-CONVULSIVE THERAPY; REMISSION RATES DID NOT DIFFER BETWEEN GROUPS. NO SHORT-TERM GROUP DIFFERENCES OCCURRED WHEN YOGA WAS COMPARED TO ANTIDEPRESSANT MEDICATION. CONFLICTING EVIDENCE WAS FOUND WHEN YOGA WAS COMPARED TO ATTENTION-CONTROL INTERVENTIONS, OR WHEN YOGA AS AN ADD-ON TO ANTIDEPRESSANT MEDICATION WAS COMPARED TO MEDICATION ALONE. ONLY TWO RCTS ASSESSED ADVERSE EVENTS AND REPORTED THAT NO TREATMENT-RELATED ADVERSE EVENTS WERE REPORTED. LIMITATIONS: FEW RCTS WITH LOW SAMPLE SIZE. CONCLUSIONS: THIS REVIEW FOUND SOME EVIDENCE FOR POSITIVE EFFECTS BEYOND PLACEBO AND COMPARABLE EFFECTS COMPARED TO EVIDENCE-BASED INTERVENTIONS. HOWEVER, METHODOLOGICAL PROBLEMS AND THE UNCLEAR RISK-BENEFIT RATIO PRECLUDE DEFINITIVE RECOMMENDATIONS FOR OR AGAINST YOGA AS AN ADJUNCT TREATMENT FOR MAJOR DEPRESSIVE DISORDER. LARGER AND ADEQUATELY POWERED RCTS USING NON-INFERIORITY DESIGNS ARE NEEDED. 2017